People

Showing 1565 People
Sort by:
  • Attila Szabo

    Attila Szabo

    Psychedelics and quasi-psychedelics in the light of contemporary research: Medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca • Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 …

  • Yoshiaki Kato

    Yoshiaki Kato

    … of Ibogaine and Ibogaine-Related Alkaloids. in The Alkaloids. Chemistry and Biology Pharmacology of Ibogaine and Ibogaine-Related Alkaloids. in The … • … of Ibogaine and Ibogaine-Related Alkaloids. in The Alkaloids. Chemistry and Biology Pharmacology of Ibogaine and Ibogaine-Related Alkaloids. in The …

  • Jerry W. Snow jr

    Jerry W. Snow jr

    Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias

  • Manjeet Mundey

    Manjeet Mundey

    Pharmacological comparison of the effect of ibogaine and 18‐methoxycoronaridine on isolated smooth muscle from the rat and guinea‐pig

  • Frank Vocci

    Frank Vocci

    Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging

  • Muhammad Imran khan

    Muhammad Imran khan

    Solution-phase parallel synthesis of N, 6-disubstituted isoquinuclidines as ibogaine analogs

  • James A. Rodger

    James A. Rodger

    Understanding the healing potential of ibogaine through a comparative and interpretive phenomenology of the visionary experience • The visionary cure of the addiction war? Ibogaine: social context, subcultural identity, and implications for drug policy

  • Lawrence Friedhoff

    Lawrence Friedhoff

    Methods and compositions for reducing tolerance to opioid analgesics using ibogaine and derivatives thereof • Methods for acute and long-term treatment of substance abuse using ibogaine • Methods and compositions for treating depression using ibogaine • Low dose administration of ibogaine for treating nicotine addiction and preventing relapse of nicotine use • Methods for acute and long-term treatment of alcohol dependence using ibogaine

  • Nicolas Tournier

    Nicolas Tournier

    Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood–brain barrier

  • Vitalis Briedis

    Vitalis Briedis

    Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection

  • Berta Gonzalez

    Berta Gonzalez

    Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits • Ibogaine modifies GDNF, BDNF and NGF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits

  • Austin-Marley Windham-Herman

    Austin-Marley Windham-Herman

    A mixed-method analysis of persisting effects associated with positive outcomes following ibogaine detoxification

  • Jeremy Carlier

    Jeremy Carlier

    Fatal Case of a 27‐Year‐Old Male After Taking Iboga in Withdrawal Treatment: GC‐MS/MS Determination of Ibogaine and Ibogamine in Iboga Roots and Postmortem …

  • Samuel B. Kombian

    Samuel B. Kombian

    Ibogaine and a total alkaloidal extract of Voacanga africana modulate neuronal excitability and synaptic transmission in the rat parabrachial nucleus in vitro

  • Susan R. Wilcox

    Susan R. Wilcox

    Ibogaine-associated cardiac arrest and death: case report and review of the literature

  • Michael Savic

    Michael Savic

    Ibogaine therapy for addiction: Consumer views from online fora

  • Tarek Saleh

    Tarek Saleh

    Ibogaine and a total alkaloidal extract of Voacanga africana modulate neuronal excitability and synaptic transmission in the rat parabrachial nucleus in vitro

  • John Gardner

    John Gardner

    Ibogaine therapy for addiction: Consumer views from online fora

  • Adrian Carter

    Adrian Carter

    Ibogaine therapy for addiction: Consumer views from online fora

  • Josselin Houenou

    Josselin Houenou

    Ibogaine-associated psychosis in schizophrenia: a case report

  • Marion Leboyer

    Marion Leboyer

    Ibogaine-associated psychosis in schizophrenia: a case report

  • Giuseppe Floresta

    Giuseppe Floresta

    Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands

  • Luís Fernando Tófoli

    Luís Fernando Tófoli

    A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment

  • Zhang Weiyuan

    Zhang Weiyuan

    Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19 • Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro

  • Roy Gerona

    Roy Gerona

    Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels • Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias